News Releases

ELAD® Liver Support System Study Initiated at Multiple U.S. Center

Vital Therapies™ Announces Presentation of ELAD® “Artificial Liver”
Data at American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting.

Vital Therapies™ Closes $28.1 Million Financing

The Rush To Test Drugs In China - Business Week

Vital Therapies™ Appoints Liver Transplant Expert to Board of Directors

ELAD® Bioartificial Liver Trial in China Achieves Significance at Halfway Point

Vital Therapies™ Receives FDA Guidance Allowing for the Shipment of ELAD Liver Assist System Cartridges to China

Vital Therapies™ Completes First Closing of $8 Million Private Equity Financing

Vital Therapies™, Inc. Receives Orphan Drug Designation for Key Component in Liver Assist Program

Massachusetts General Hospital Patient Saved by ELAD®